Moreover, since the discovery that the interaction with ERRα renders PGC1α a regulator of hypoxia-independent vasculogenesis via transcription of the Vascular Endothelial Growth Factor (VEGF)17, more attention has been paid to PGC1α in cancer. This evidence concerns the gene PPARGC1A and cancer.